Effect of aflibercept on proliferative vitreoretinopathy: Proteomic analysis in an experimental animal model

被引:5
|
作者
Uslubas, Isil [1 ,3 ]
Kanli, Aylin [2 ]
Kasap, Murat [2 ]
Akpinar, Gurler [2 ]
Karabas, Levent [1 ]
机构
[1] Kocaeli Univ, Dept Ophthalmol, Sch Med, Kocaeli, Turkey
[2] Kocaeli Univ, Dept Med Biol, Sch Med, Kocaeli, Turkey
[3] Golcuk Necati Celik State Hosp, TR-41650 Kocaeli, Turkey
关键词
Proliferative vitreoretinopathy; Aflibercept; Dispase; Proteomic; Animal model;
D O I
10.1016/j.exer.2020.108425
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to monitor inflammatory, proliferative and progressive effects of proliferative vitreoretinopathy (PVR) and aflibercept treatment in dispase induced PVR rat model by proteomic analysis. Material and methods: A total of 35 male Long Evans pigmented rats were divided into three groups, namely, PVR (dispase+saline), PVR+aflibercept (dispase+aflibercept) and control. The PVR group received 2 mu l of 0.03 IU/mu l dispase and 2 mu l saline, the PVR+aflibercept group received 2 mu l of 0.03 IU/mu l and 2 mu l of 40 mg/ml aflibercept at the first day of the experiment. At the end of the 6th week all retina and vitreous specimens were collected by evisceration and transferred to the proteomics laboratory for analysis. Proteomic analysis by 2D gel electrophoresis coupled with MALDI-TOF/TOF was performed. Results: In the PVR and PVR+aflibercept group 16 different proteins that were identified to be differentially regulated in comparison to the control group. In the PVR+aflibercept group, ENO1, ENO2, LDH-B, PEBP-1 and GS levels were higher than the PVR group. In addition, the association of proteins such as UCHL, PEBP1, PDHB and ENO1 with PVR has been demonstrated for the first time. Conclusion: STRING analysis elucidated the functional protein-protein interaction among the differentially regulated proteins and highlighted that those proteins mainly played roles in carbon and nucleotide metabolisms. Functional analysis of the differentially regulated proteins indicated the presence of inflammation, gliosis and retinal damage in the PVR group. Aflibercept treatment had pronounced effect on prevention of inflammation and retinal damage while causing a slight increase in gliosis. However, aflibercept treatment was not effective enough to normalize the levels of differentially regulated proteins of the PVR group. Therefore, we predict that the treatment dose of aflibercept used in this study was below of its ideal concentration and should be increased in the future studies. The differential regulation of these structural proteins in this study should shed some light to the mechanism of glial wound formation in the retina and guide future treatment modalities.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes
    Ozer, Murat Atabey
    Polat, Nihat
    Ozen, Serkan
    Ogurel, Tevfik
    Parlakpinar, Hakan
    Vardi, Nigar
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (03) : 599 - 605
  • [22] Endogenous or Exogenous Retinal Pigment Epithelial Cells: A Comparison of Two Experimental Animal Models of Proliferative Vitreoretinopathy
    Wong, Chee Wai
    Busoy, Joanna Marie Fianza
    Cheung, Ning
    Barathi, Veluchamy Amutha
    Storm, Gert
    Wong, Tina T.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (09): : 1 - 10
  • [23] THE IMPACT OF TACROLIMUS ON GROWTH FACTORS IN EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY
    Turgut, Burak
    Uyar, Fatma
    Ustundag, Bilal
    Celiker, Ulku
    Akpolat, Nusret
    Demir, Tamer
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (02): : 232 - 241
  • [24] The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy
    Tahara, Y
    Sakamoto, T
    Oshima, Y
    Ishibashi, T
    Inomata, H
    Murata, T
    Hinton, DR
    Ryan, SJ
    CURRENT EYE RESEARCH, 1999, 19 (04) : 323 - 329
  • [25] IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy
    Bali, E
    Willermain, F
    Caspers-Velu, L
    Dubois, C
    Dehou, MF
    Velu, T
    Libert, J
    Bruyns, C
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (03) : 305 - 310
  • [26] The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy
    Kuo, Hsi-Kung
    Chen, Yi-Hao
    Wu, Pei-Chang
    Kuo, Yu-Hsia
    OPHTHALMOLOGICA, 2015, 233 (3-4) : 198 - 203
  • [27] Upregulation of TGF-1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition
    Hoerster, Robert
    Muether, Philipp S.
    Vierkotten, Sarah
    Hermann, Manuel M.
    Kirchhof, Bernd
    Fauser, Sascha
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (01) : 11 - 16
  • [28] Upregulation of TGF-ß1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition
    Robert Hoerster
    Philipp S. Muether
    Sarah Vierkotten
    Manuel M. Hermann
    Bernd Kirchhof
    Sascha Fauser
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 11 - 16
  • [29] Evaluation of a steroid delivery system to mitigate the severity of proliferative vitreoretinopathy in a minipig model
    Wong, Chee Wai
    Cheung, Ning
    Howden, James S.
    Busoy, Joanna Marie Fianza
    Sim, Shaun
    Lim, Joshua
    Ho, Candice
    Veluchamy, Amutha Barathi
    Storm, Gert
    Wong, Tina T.
    FRONTIERS IN OPHTHALMOLOGY, 2023, 3
  • [30] ANALYSIS OF THE MOLECULAR BIOLOGIC MILIEU OF THE VITREOUS IN PROLIFERATIVE VITREORETINOPATHY
    Wladis, Edward J.
    Falk, Naomi S.
    Iglesias, Bibiana V.
    Beer, Paul M.
    Gosselin, Edmund J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (04): : 807 - 811